×
About 4,773 results

ALLMedicine™ Angioedema Center

Research & Reviews  1,225 results

Hereditary Angioedema of the Small Bowel.
https://doi.org/10.1007/s11605-021-05135-6 10.1056/NEJMra1808012 10.2500/aap.2019.40.4267
Journal of Gastrointestinal Surgery : Official Journal Of... Huang WF, Yu J et. al.

Sep 11th, 2021 - Hereditary Angioedema of the Small Bowel.|2021|Huang WF,Yu J,Liu W,|

Variability of disease activity in patients with hereditary angioedema type 1/2: longit...
https://doi.org/10.1111/jdv.17654
Journal of the European Academy of Dermatology and Venere... Maurer M, Caballero T et. al.

Sep 11th, 2021 - Hereditary angioedema due to C1 inhibitor deficiency (HAE-1/2) is a chronic and debilitating disease. The unpredictable clinical course represents a significant patient burden. To analyze longitudinal registry data from the Icatibant Outcome Surve...

gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema.
https://doi.org/10.1007/s10753-021-01532-w 10.1097/WOX.0b013e31817aecbe 10.1016/0091-6749(83)90052-0 10.1016/j.clim.2004.05.007 10.1078/0171-2985-00143 10.1016/j.molimm.2004.03.014 10.1006/clim.1999.4753 10.1007/0-387-34134-X_7 10.1016/j.molimm.2010.05.010 10.1161/01.RES.70.5.1018 10.1172/JCI200214211 10.1016/0006-2952(86)90727-6 10.1111/j.1476-5381.1995.tb15108.x 10.3390/pharmacy6020043 10.1161/01.CIR.101.15.1867 10.1038/sj.bjp.0702328 10.1016/j.molimm.2006.11.012 10.1016/j.thromres.2007.11.005 10.1098/rsif.2011.0177 10.2147/TCRM.S3172 10.1016/j.jaci.2009.08.007 10.1089/hyb.1996.15.333 10.1111/j.1538-7836.2006.02065.x 10.1016/j.thromres.2010.11.021 10.3109/09537104.2011.585257 10.1016/j.thromres.2016.12.003 10.4049/jimmunol.173.11.6921 10.1111/jdi.12162 10.1007/s12195-019-00585-0 10.1084/jem.147.2.488 10.3389/fbioe.2020.00369 10.1114/1.1385811 10.1016/j.cardiores.2007.04.017 10.3389/fcell.2019.00044 10.4049/jimmunol.168.5.2441 10.1160/TH03-04-0231 10.1097/TME.0000000000000211 10.1016/j.jemermed.2012.07.055 10.1016/S1567-5769(02)00162-5 10.1111/j.1476-5381.1967.tb02148.x 10.1152/ajpheart.2001.281.1.H275 10.1016/j.molimm.2017.01.028 10.1016/j.jaci.2013.12.1072 10.1016/j.jaci.2011.02.017 10.3389/fimmu.2011.00058 10.1016/j.iac.2013.07.008 10.1007/978-1-4614-4118-2_6 10.1016/j.jaci.2010.08.012
Inflammation Fandaros M, Joseph K et. al.

Sep 9th, 2021 - Angioedema is characterized by swelling of the skin or mucous membranes. Overproduction of the vasodilator bradykinin (BK) is an important contributor to the disease pathology, which causes rapid increase in vascular permeability. BK formation on ...

Urticaria and angioedema associated with SARS-CoV-2 infection.
https://doi.org/10.1503/cmaj.211087
CMAJ : Canadian Medical Association Journal = Journal De ... Zipursky JS, Croitoru D

Sep 9th, 2021 - Urticaria and angioedema associated with SARS-CoV-2 infection.|2021|Zipursky JS,Croitoru D,|

Effect of COVID-19 on hereditary angioedema activity and quality of life.
https://doi.org/10.2500/aap.2021.42.210066
Allergy and Asthma Proceedings; Can Bostan O, Tuncay G et. al.

Sep 4th, 2021 - Background: The demonstration that severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) enters the cell via the angiotensin-converting enzyme 2 receptor has raised concerns that, in hereditary angioedema (HAE), a disease characterized...

see more →

Guidelines  4 results

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2...
https://doi.org/10.1111/all.13384
Allergy Maurer M, Magerl M et. al.

Jan 11th, 2018 - Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. I...

A consensus parameter for the evaluation and management of angioedema in the emergency ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100605
Academic Emergency Medicine : Official Journal of the Soc... Moellman JJ, Bernstein JA et. al.

Apr 16th, 2014 - Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioed...

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, an...
https://doi.org/10.1016/j.jaci.2013.03.034
The Journal of Allergy and Clinical Immunology; Zuraw BL, Bernstein JA et. al.

Jun 4th, 2013 - These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council ...

International consensus and practical guidelines on the gynecologic and obstetric manag...
https://doi.org/10.1016/j.jaci.2011.11.025
The Journal of Allergy and Clinical Immunology; Caballero T, Farkas H et. al.

Dec 27th, 2011 - There are a limited number of publications on the management of gynecologic/obstetric events in female patients with hereditary angioedema caused by C1 inhibitor deficiency (HAE-C1-INH). We sought to elaborate guidelines for optimizing the managem...

see more →

Drugs  526 results see all →

Clinicaltrials.gov  1 results

Coreg and HSRs-Updated Analysis
https://clinicaltrials.gov/ct2/show/NCT01316952

Apr 15th, 2015 - A cluster of reports of hypersensitivity reactions among patients who switched from carvedilol (immediate release formulation, referred to hereafter as carvedilol) to carvedilol extended release was received during the initial post-launch period o...

see more →

News  153 results

Considerations in SM: Hereditary Alpha Tryptasemia
https://www.onclive.com/view/considerations-in-sm-hereditary-alpha-tryptasemia

Aug 16th, 2021 - Dan DeAngelo, MD, PhD: Concerning this newer entity of hereditary alpha tryptasemia, or HAT, how does this play into your algorithm? Patricia Lugar, MD, MS: We have a few patients we follow in the clinic who meet the criteria for familial alpha...

FDA Approves Myrbetriq to Treat Pediatric NDO
https://www.medscape.com/viewarticle/948305

Mar 29th, 2021 - The US Food and Drug Administration (FDA) has expanded the indication for Mirabegron (Myrbetriq/Myrbetriq Granules) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurologic impairment, in children aged 3 years a...

FDA Approvals, Highlights, and Summaries
https://reference.medscape.com/viewarticle/945186

Feb 24th, 2021 - Allergy/Immunology Orladeyo (berotralstat) Berotralstat is the first oral kallikrein inhibitor approved for prophylaxis of hereditary angioedema (HAE) attacks in patients aged 12 years and older. Kallikrein is a protease that cleaves high-molecula...

Fast Five Quiz: Food Allergies
https://reference.staging.medscape.com/viewarticle/936716_3

Sep 8th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...

For Patients with HFrEF, What Is the Role for and Treatment Pearls for ARNI?
https://decisionpoint.medscape.com/cardiology/viewarticle/926451

May 21st, 2020 - This transcript has been edited for clarity. The data with angiotensin receptor neprilysin inhibitor (ARNI) therapy, valsartan sacubitril, continue to evolve in terms of its role in the patient’s management with heart failure reduced ejection frac...

see more →